XML 25 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Cash flows from operating activities:    
Net income (loss) $ 782,916 $ 451,943
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 131,388 132,772
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions (164,930) (140,387)
Provision for current expected credit losses 2,961 1,472
Deferred taxes (1,733) 11,856
Other, net 1,597 (8,556)
Changes in operating assets and liabilities, net of acquisitions:    
Receivables (779,455) (696,984)
Inventories (1,417,233) (1,274,141)
Accounts payable and accrued expenses 1,441,469 1,420,237
Other liabilities (177,172) (81,799)
Net cash provided by (used in) operating activities (180,192) (183,587)
Cash flows from investing activities:    
Acquisition of property, plant and equipment (122,598) (74,878)
Proceeds from disposition of property, plant and equipment 5,034 2,822
Expenditures for major repairs (27,398) (5,541)
Proceeds from Sales of Business, Affiliate and Productive Assets 0 55,546
Changes in CHS Capital notes receivable, net 32,098 (31,509)
Financing extended to customers (39,814) (456)
Payments from customer financing 42,121 3,833
Other investing activities, net (156) (2,013)
Net cash provided by (used in) investing activities (110,713) (52,196)
Cash flows from financing activities:    
Proceeds from lines of credit and long-term borrowings 2,054,507 4,952,834
Payments on lines of credit, long-term borrowings and capital lease obligations (1,887,483) (4,792,770)
Preferred stock dividends paid (42,167) (42,167)
Redemptions of equities (12,941) (12,221)
Other financing activities, net 18,044 50,326
Net cash provided by (used in) financing activities 129,960 156,002
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1,415 (3,550)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (159,530) (83,331)
Cash and cash equivalents and restricted cash at beginning of period 903,474 542,484
Cash and cash equivalents and restricted cash at end of period $ 743,944 $ 459,153